Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Antipsychotic Drugs: Typical and Atypical Agents

Antipsychotic Drugs: Typical and Atypical Agents

Antipsychotic drugs are classified into first-generation (typical) drugs including phenothiazines; and second-generation (atypical) drugs. Chlorpromazine hydrochloride (Thorazine), a phenothiazine derivative, broadly impacts the central, autonomic, and endocrine systems. This drug, along with typical agents like haloperidol (Haldol), primarily works by antagonizing D2 receptors, thus reducing dopaminergic neurotransmission. However, typical antipsychotics can cause side effects such as sedation...

Psychosis: Goals of Pharmacotherapy

Psychosis: Goals of Pharmacotherapy

Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation. For...

Psychosis and Antipsychotic Drugs: Overview

Psychosis and Antipsychotic Drugs: Overview

The term "psychosis" refers to a spectrum of mental disorders characterized by abnormal thoughts, perceptions, and behaviors. It can manifest as mood disorders, dementia, delirium with psychotic features, substance-induced psychosis with psychotic features, brief psychotic disorder, delusional disorder, schizoaffective disorder, and schizophrenia. Among all these disorders, schizophrenia is the most common psychotic disorder, affecting 1% of the worldwide population. Psychotic symptoms in all...

Drug Therapy

Drug Therapy

The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications

Antipsychotic Drugs: Therapeutic Uses and Side Effects

Antipsychotic Drugs: Therapeutic Uses and Side Effects

Antipsychotic drugs primarily block dopamine and serotonin receptors and cholinergic, adrenergic, and histaminergic receptors, thereby reducing hallucinations and delusions in conditions like schizophrenia. However, they can trigger unwanted extrapyramidal effects such as dystonias, Parkinson-like symptoms, and tardive dyskinesia.
Despite these side effects, antipsychotics are used therapeutically for various purposes, including managing schizophrenia, preventing nausea and vomiting, curbing...

Insulin Formulations: Types and Delivery

Insulin Formulations: Types and Delivery

Insulin preparations are categorized by their duration of action into short-acting and long-acting types. Two strategies are used to modify insulin's absorption and pharmacokinetic profile: slowing the absorption post-subcutaneous injection, or altering human insulin's amino acid sequence or protein structure. These changes retain the insulin's ability to bind to the insulin receptor, but alter its behavior in solution or after injection.
Short-acting insulins are divided into rapid-acting...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Contextualizing the Future <i>DSM</i>: Cross-Cultural, Developmental, and Multi-Informant Considerations.

The American journal of psychiatry·2026

Same author

Validation of the Temper Outbursts/Irritability-2: A Two-Item Screener for Temper Outbursts and Irritability in Youth.

Journal of child and adolescent psychopharmacology·2026

Same author

Do We Really Care About Our Children's School Safety? The Proof Is in the Pudding.

WMJ : official publication of the State Medical Society of Wisconsin·2026

Same author

Treatment patterns and comparative clinical outcomes of ADHD medications in adolescents and young adults with comorbid major depressive disorder.

Journal of affective disorders·2026

Same author

Pediatric Posttraumatic Stress Disorder Treatment Patterns: Insights from a Large Retrospective Study.

Journal of clinical psychopharmacology·2026

Same author

Association of SGLT2 inhibitors with suicidality, all-cause mortality, and hospitalization in bipolar disorder: A cohort study of 1.23 million adults.

Journal of affective disorders·2026

Search research articles

Related Experiment Video

Updated: May 25, 2026

Rating L-DOPA-Induced Dyskinesias in the Unilaterally 6-OHDA-Lesioned Rat Model of Parkinson's Disease

Rating L-DOPA-Induced Dyskinesias in the Unilaterally 6-OHDA-Lesioned Rat Model of Parkinson's Disease

Published on: October 4, 2021

Long-acting antipsychotic medications.

Raman Baweja¹, Karim Sedky, Steven Lippmann

¹Drexel University, Friends Hospital, Philadelphia, PA 19124, USA.

Current Drug Targets

|January 19, 2012

Summary

Long-acting injectable antipsychotics can improve treatment adherence for patients with psychotic disorders, potentially reducing relapses and improving outcomes. This approach is particularly beneficial for individuals with severe symptoms or substance abuse issues.

More Related Videos

Dual Extracellular Recordings in the Mouse Hippocampus and Prefrontal Cortex

Dual Extracellular Recordings in the Mouse Hippocampus and Prefrontal Cortex

Published on: February 16, 2024

Related Experiment Videos

Last Updated: May 25, 2026

Rating L-DOPA-Induced Dyskinesias in the Unilaterally 6-OHDA-Lesioned Rat Model of Parkinson's Disease

Rating L-DOPA-Induced Dyskinesias in the Unilaterally 6-OHDA-Lesioned Rat Model of Parkinson's Disease

Published on: October 4, 2021

Dual Extracellular Recordings in the Mouse Hippocampus and Prefrontal Cortex

Dual Extracellular Recordings in the Mouse Hippocampus and Prefrontal Cortex

Published on: February 16, 2024

Area of Science:

Psychiatry
Pharmacology

Background:

Antipsychotic medications are essential for managing psychotic disorders.
Treatment non-compliance in psychotic patients often leads to relapses and poor outcomes.
Continuous management of psychosis improves patient quality of life and reduces healthcare costs.

Purpose of the Study:

To evaluate the role of long-term parenteral antipsychotic agents in improving treatment compliance.
To identify patient subgroups that may particularly benefit from injectable antipsychotic therapy.

Main Methods:

Review of existing literature on antipsychotic pharmacotherapy and adherence.
Analysis of the benefits of long-acting injectable (LAI) antipsychotics.
Discussion of individualized treatment approaches using available depot formulations.

Main Results:

Long-term parenteral antipsychotics provide documented evidence of drug administration and monitoring.
Injectable therapy can significantly improve compliance in non-compliant patients.
LAI antipsychotics are especially beneficial for first-episode psychosis, severe psychopathology, and comorbid substance abuse.

Conclusions:

Long-acting injectable antipsychotics offer a valuable strategy to enhance medication adherence in psychotic disorders.
Individualized treatment selection from diverse depot antipsychotic options can optimize patient care.
Improved compliance through parenteral administration can lead to better clinical outcomes and reduced hospitalizations.